Related Experiment Videos
Mycophenolate mofetil and skin diseases.
1Department of Dermatology, University of Heidelberg, Heidelberg, Germany. Martin-Hartmann@med.uni-heidelberg.de
Lupus
|April 5, 2005
Summary
Mycophenolate mofetil (MMF) shows promise for treating certain skin conditions like psoriasis and atopic dermatitis. However, more placebo-controlled trials are needed to confirm its effectiveness as a first-line therapy for these dermatological diseases.
Area of Science:
- Immunodermatology
- Pharmacology
Background:
- Mycophenolate mofetil (MMF) is an established immunosuppressant in renal transplantation.
- Emerging evidence suggests MMF's potential in treating lymphocyte-mediated skin diseases.
Purpose of the Study:
- To review the efficacy of MMF in various dermatological conditions.
- To assess the current evidence for MMF as a treatment for skin diseases.
Main Methods:
- Literature review of studies investigating MMF in dermatology.
- Analysis of reported efficacy in autoimmune bullous dermatoses, atopic dermatitis, and psoriasis.
Main Results:
- MMF has demonstrated efficacy in treating specific skin conditions.
- Evidence suggests MMF is effective for autoimmune bullous dermatoses, atopic dermatitis, and psoriasis.
Conclusions:
- MMF shows potential for treating certain immune-mediated skin diseases.
- Further placebo-controlled trials are necessary to establish MMF as a first-line therapy for these dermatoses.